During the past decade, Althaia Xarxa Assistencial Universitària de Manresa conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 7 clinical trials were completed, i.e. on average, 17.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Althaia Xarxa Assistencial Universitària de Manresa" #1 sponsor was "PETHEMA Foundation" with 10 trials, followed by "Althaia Xarxa Assistencial Universitària de Manresa" with 7 trials sponsored, "Spanish Breast Cancer Research Group" with 7 trials sponsored, "Pfizer" with 5 trials sponsored and "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 5 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Althaia Xarxa Assistencial Universitària de Manresa" #1 collaborator was "Althaia Xarxa Assistencial Universitària de Manresa" with 4 trials as a collaborator, "Astellas Pharma Inc" with 4 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator and "Celgene" with 2 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Althaia Xarxa Assistencial Universitària de Manresa" are "Breast Cancer" (6 trials), "Prostate Cancer" (5 trials), "Advanced Prostate Cancer" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Althaia Xarxa Assistencial Universitària de Manresa" in a lesser frequency.

Most popular intervention types in "Althaia Xarxa Assistencial Universitària de Manresa" are "Drug" (37 trials), "Other" (12 trials), "Procedure" (8 trials), "Device" (6 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Prednisone" (5 trials), "Cyclophosphamide" (4 trials), "Docetaxel" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Althaia Xarxa Assistencial Universitària de Manresa" are 55 trials for "All" genders, 10 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Althaia Xarxa Assistencial Universitària de Manresa". undefined are not yet recruiting, 16 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Althaia Xarxa Assistencial Universitària de Manresa, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Althaia Xarxa Assistencial Universitària de Manresa, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 14 trials that are defined as “Not Applicable".

Althaia Xarxa Assistencial Universitària de Manresa has several departments that took part in Clinical trials: "Complejo Hospitalario de Althaia; Servicio de Oncologia" - 3 trials